Search - tctmd.com

Displaying 221 - 240 of 318

Sort: Relevancy | Date

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

May 18, 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

May 16, 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

May 15, 2021

Women Treated for Acute HF Report Worse QoL Than Men

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

March 12, 2021

March 2021 News Roundup

News Opinion CV Team Dispatch

March 2021 News Roundup

March 01, 2021

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

News Daily News

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

February 24, 2021

TCTMD’s Top 10 Most Popular Stories for January 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2021

February 03, 2021

February 2021 News Roundup

News Opinion CV Team Dispatch

February 2021 News Roundup

February 01, 2021

Despite COVID-19 Heart Disease Remains Top US Killer AHA (1).jpeg

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

Hospitalization for HF After Acute MI More Common in Women Than Men

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

January 15, 2021

More Women Than Men Develop HF or Die After STEMI

News Daily News

More Women Than Men Develop HF or Die After STEMI

December 01, 2020

TCTMD’s Top 10 Most Popular Stories for November 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

November 30, 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

November 17, 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

News Conference News AHA 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

November 16, 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

September 22, 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

August 30, 2020

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.